Barrett's esophagus: pathogenesis, treatment, and prevention.
Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.
Badreddine
Rami J
RJ
Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Wang
Kenneth K
KK
D001471:Barrett Esophagus / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control / Q000601:surgery*; D004945:Esophagoscopy; D006801:Humans; D011379:Prognosis